种族与医疗保险覆盖对儿童心脏移植注册及等待期死亡率的影响
该研究基于儿童心脏移植学会多中心注册库2000年1月1日至2019年12月31日前瞻性收集的数据,比较不同种族和保险覆盖状态患儿的注册临床状况与等待期结局。结果显示黑人患儿注册时年龄更大、病情更重,等待期更短但等待期死亡率更高,该差异由早期(2000-2009)驱动,近期(2010-2019)无差异。
要点
- 黑人患儿注册时更年长、更多使用政府保险、以心肌病为主,且更高比例处于住院、正性肌力药或心室辅助装置状态。
- 黑人患儿等待期更短,但等待期死亡率更高,差异集中于2000-2009年,尤其美国私人保险队列。
- 近期(2010-2019)各保险队列结局无差异,作者认为与美国近期医疗改革相关。
核心结论
- 黑人儿童注册时更年长、病情更重、更常恶化且等待期死亡率更高,尽管等待期更短且临床因素有利,近期改善与美国近期医疗改革相关。
- 作者认为种族这一社会建构似乎通过限制转诊、考虑或获得儿童心脏移植的机会使黑人儿童处于不利地位。
研究设计与样本
- 研究分析了儿童心脏移植学会多中心注册库2000年1月1日至2019年12月31日前瞻性收集的数据。
- 患儿按种族分为黑人、白人和其他,按注册时保险覆盖分为美国政府保险、美国私人保险和非美国单一支付系统(英国、加拿大)。
- 分类变量采用卡方检验,连续变量采用Wilcoxon秩和检验,等待期死亡危险因素采用多相参数风险模型,并用参数风险模型进行敏感性分析探索种族与保险的交互作用。
主要发现
- 注册时黑人患儿(n=1428)较白人(n=5391)和其他(n=1167)更年长、更可能使用美国政府保险、以心肌病为主要诊断(p<0.0001)。
- 黑人患儿注册时更可能处于更高状态、住院、使用正性肌力药或心室辅助装置(p<0.0001)。
- 黑人患儿等待期显著短于其他种族(p<0.0001),但等待期死亡率更高(p=0.0091),差异由早期(2000-2009)驱动(p=0.0005),最突出于美国私人保险队列(p=0.015)。
- 其他保险队列或近期(2010-2019)结局无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Social factors like race and insurance affect transplant outcomes. However, little is known in pediatric heart transplantation. We hypothesized that race and insurance coverage impact listing and waitlist outcomes across eras. METHODS: Data from the Pediatric Heart Transplant Society multi-center registry prospectively collected between January 1, 2000-December 31, 2019 were analyzed. Patients were divided by race as Black, White and other and by insurance coverage at listing (US governmental, US private and non-US single payer systems (UK, Canada). Clinical condition at listing and waitlist outcomes were compared across races and insurance coverages. Categorical variables were compared using a chi-square test and continuous variables using the Wilcoxon rank sum test. Risk factors for waitlist mortality were examined using multiphase parametric hazard modeling. A sensitivity analysis using parametric hazard explored the interaction between race and insurance. RESULTS: At listing, compared to Whites (n = 5391) and others (n = 1167), Black patients (n = 1428) were older, more likely on US governmental insurance and had cardiomyopathy as the predominant diagnosis (p < 0.0001). Black patients were more likely to be higher status at listing, in hospital, on inotropes or a ventricular assist device (p < 0.0001). Black patients had significantly shorter time on the waitlist compared to other races (p < 0.0001) but had higher waitlist mortality (p = 0.0091), driven by the earlier era (2000-2009) (p = 0.0005), most prominently within the US private insurance cohort (p = 0.015). Outcomes were not different in other insurance cohorts or in the recent era (2010-2019). CONCLUSION: Black children are older and sicker at the time of listing, deteriorate more often and face a higher wait list mortality, despite a shorter waitlist period and favorable clinical factors, with improvement in the recent era associated with the recent US healthcare reforms. The social construct of race appears to disadvantage Black children by limiting referral, consideration or access to pediatric cardiac transplantation.
引用
- Bansal N, Lal AK, Koehl D, et al. Impact of race and health coverage on listing and waitlist mortality in pediatric cardiac transplantation. J Heart Lung Transplant. 2022. PMID: 36641295. doi:10.1016/j.healun.2022.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。